The relationship between RRM1 gene polymorphisms and effectiveness of gemcitabine-based first-line chemotherapy in advanced NSCLC patient

PURPOSE: Chemotherapy with platinum compounds and gemcitabine is frequently used in first-line treatment of advanced non-small cell lung cancer (NSCLC) patients in which tyrosine kinase inhibitors (EGFR or ALK) cannot be administered. Unfortunately, less than half of the patients achieve the benefit...

全面介紹

Na minha lista:
書目詳細資料
發表在:Clin Transl Oncol
Main Authors: Mlak, R., Krawczyk, P., Ciesielka, M., Kozioł, P., Homa, I., Powrózek, T., Prendecka, M., Milanowski, J., Małecka-Massalska, T.
格式: Artigo
語言:Inglês
出版: Springer International Publishing 2015
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4995236/
https://ncbi.nlm.nih.gov/pubmed/26650486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12094-015-1461-1
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍